Arena Pharma (ARNA) Tops Q4 EPS by 24c
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Price: $99.98 --0%
Financial Fact:
Research and development: 17.47M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 17.47M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Arena Pharma (NASDAQ: ARNA) reported Q4 EPS of $0.16, $0.24 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $85.4 million versus the consensus estimate of $15.58 million.
For earnings history and earnings-related data on Arena Pharma (ARNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- The LGL Group (LGL) Misses Q2 EPS by 8c
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
